MYTHIC Trial
MYTHIC Trial Significance Statement Single-center trials and retrospective case series have reported promising outcomes transplanting kidneys from donors with hepatitis C virus (HCV) infection into [...]
LATEST TWEETS
Recent Publications
Paul Hanna2022-02-14T08:43:04-05:00
MYTHIC Trial Significance Statement Single-center trials and retrospective case series have reported promising outcomes transplanting kidneys from donors with hepatitis C virus (HCV) infection into [...]
Paul Hanna2022-02-14T07:40:58-05:00
COVID-19 Survival and its impact on chronic kidney disease Abstract Up to 87% of patients hospitalized with coronavirus disease 2019 (COVID-19) experience chronic sequelae following [...]
Paul Hanna2022-02-14T07:52:43-05:00
Renal Toxicities with Immune Checkpoint Inhibitors Abstract Immune checkpoint inhibitors are now approved for more than 50 indications, and increasing numbers of patients with advanced [...]
© All rights reserved • Onconephrology.MGH.Harvard.edu • 2022